Ftse Mib
34.791,95
-0,85%
DAX
20.132,85
-0,44%
S&P 500
5.804,71
-0,38%
NASDAQ
18.956,55
-1,07%
Bitcoin
92.198,79
-2,42%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 180 Life Sciences Corporation (ATNF) 180 Life Sciences Corporation (ATNF) Notizie

ATNF

180 Life Sciences (ATNF)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ATNF
DataOraFonteTitoloSimboloCompagnia
25/10/202415:00GlobeNewswire Inc.Elray Resources Announces Strategic Sale of Crypto iGaming TechnologyNASDAQ:ATNF180 Life Sciences Corporation
12/09/202422:15GlobeNewswire Inc.180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial OfficerNASDAQ:ATNF180 Life Sciences Corporation
12/08/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATNF180 Life Sciences Corporation
30/07/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
30/07/202414:00GlobeNewswire Inc.180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral UptakeNASDAQ:ATNF180 Life Sciences Corporation
23/07/202414:00GlobeNewswire Inc.180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing RequirementsNASDAQ:ATNF180 Life Sciences Corporation
19/07/202422:15Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ATNF180 Life Sciences Corporation
02/07/202414:30GlobeNewswire Inc.180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing RequirementsNASDAQ:ATNF180 Life Sciences Corporation
14/03/202413:30GlobeNewswire Inc.180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:ATNF180 Life Sciences Corporation
28/02/202412:42Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
26/02/202413:00GlobeNewswire Inc.180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanNASDAQ:ATNF180 Life Sciences Corporation
29/12/202300:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATNF180 Life Sciences Corporation
27/12/202322:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATNF180 Life Sciences Corporation
26/12/202322:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
14/12/202322:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
04/12/202315:00GlobeNewswire Inc.180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesNASDAQ:ATNF180 Life Sciences Corporation
28/11/202315:00GlobeNewswire Inc.180 Life Sciences Announces Review of Strategic AlternativesNASDAQ:ATNF180 Life Sciences Corporation
30/08/202322:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ATNF180 Life Sciences Corporation
14/08/202323:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ATNF180 Life Sciences Corporation
14/08/202322:29GlobeNewswire Inc.180 Life Sciences Corp. Announces Closing of $3 Million Public OfferingNASDAQ:ATNF180 Life Sciences Corporation
10/08/202314:46GlobeNewswire Inc.180 Life Sciences Corp. Announces Pricing of $3 Million Public OfferingNASDAQ:ATNF180 Life Sciences Corporation
10/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATNF180 Life Sciences Corporation
07/08/202315:00GlobeNewswire Inc.180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral UptakeNASDAQ:ATNF180 Life Sciences Corporation
03/08/202314:00GlobeNewswire Inc.180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDANASDAQ:ATNF180 Life Sciences Corporation
31/07/202314:00GlobeNewswire Inc.180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress AppetiteNASDAQ:ATNF180 Life Sciences Corporation
25/07/202323:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ATNF180 Life Sciences Corporation
02/06/202314:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATNF180 Life Sciences Corporation
15/05/202323:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ATNF180 Life Sciences Corporation
15/05/202322:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATNF180 Life Sciences Corporation
15/05/202312:36Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ATNF180 Life Sciences Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ATNF

La tua Cronologia

TSXV
DB.WT
Decibel Cannabis
BIT
F16972
Vontobel Financial Produ...
BIT
I10451
IT0005615932 20250303 6.8
NASDAQ
NSTDX
Columbia Short Term Bond...
NASDAQ
CBXUX
Ci Canadian Equity Corpo...
NASDAQ
CEHCX
Ci Global Smallmid Cap E...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network